Melbourne patients world’s first to gain access to drug trial

MELBOURNE: Melbourne patients will be the first in the world to access a breakthrough Alzheimer’s drug shown to wake people up from the devastating impacts of dementia.

Up to 300 Australians will be offered the chance to trial experimental drug Anavex 2-73 next year in a study hoped to be the biggest step since the 1990s in treating the disease.

The Phase II-III trial comes as results from an early stage trial revealed Anavex not only halted the progression of dementia, but even reversed its impact and restored functions.

Full story covered in the Dementia Business Weekly.